Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness of ondansetron (Zofran) and naltrexone (ReVia) both
alone and in combination in treating Early Onset Alcoholics versus Late Onset Alcoholics. All
subjects will received standardized Cognitive Behavioral Therapy. Followup assessments will
be completed at 1, 3, 6, and 9 months after treatment.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)